KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.30 Friday, 26th Apr 2024 CTMX stock ended at $1.59. This is 0.625% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.77% from a day low at $1.59 to a day high of $1.65.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Jul 15, 2021 $5.76 $5.89 $5.69 $5.88 717 075
Jul 14, 2021 $5.95 $5.98 $5.80 $5.80 839 138
Jul 13, 2021 $6.11 $6.15 $5.81 $5.96 1 036 513
Jul 12, 2021 $6.06 $6.14 $5.99 $6.12 421 384
Jul 09, 2021 $6.04 $6.11 $5.92 $6.07 481 490
Jul 08, 2021 $5.83 $6.11 $5.82 $6.00 488 122
Jul 07, 2021 $6.12 $6.12 $5.87 $5.92 868 097
Jul 06, 2021 $6.27 $6.30 $6.05 $6.08 453 894
Jul 02, 2021 $6.46 $6.47 $6.11 $6.24 755 248
Jul 01, 2021 $6.40 $6.45 $6.26 $6.43 857 978
Jun 30, 2021 $6.48 $6.52 $6.33 $6.33 893 417
Jun 29, 2021 $6.54 $6.60 $6.45 $6.47 816 790
Jun 28, 2021 $6.55 $6.70 $6.47 $6.49 831 398
Jun 25, 2021 $6.73 $6.73 $6.42 $6.45 2 333 354
Jun 24, 2021 $6.75 $6.78 $6.61 $6.70 726 898
Jun 23, 2021 $6.91 $7.00 $6.64 $6.68 853 517
Jun 22, 2021 $7.00 $7.07 $6.79 $6.93 718 700
Jun 21, 2021 $7.21 $7.33 $6.94 $7.05 756 075
Jun 18, 2021 $7.14 $7.22 $6.94 $7.18 2 249 119
Jun 17, 2021 $7.13 $7.24 $7.05 $7.17 396 470
Jun 16, 2021 $7.01 $7.16 $6.88 $7.13 568 242
Jun 15, 2021 $7.27 $7.27 $7.07 $7.08 462 357
Jun 14, 2021 $7.17 $7.30 $7.15 $7.24 572 060
Jun 11, 2021 $7.19 $7.28 $7.10 $7.16 354 131
Jun 10, 2021 $7.06 $7.30 $7.03 $7.22 387 696
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT